Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-08-12 17:38:37
Reporting Period:
Accepted Time:
2020-08-12 17:38:37
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1135139 Phd Chaitan Khosla C/o Protagonist Therapeutics, Inc.
7707 Gateway Blvd., Suite 140
Newark CA 94560
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-11 2,499 $1.89 2,499 No 4 M Direct
Common Stock Disposition 2020-08-11 2,499 $17.19 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2020-08-11 2,499 $0.00 2,499 $1.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,499 2024-10-22 No 4 M Direct
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.91 to $17.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. This option is fully vested.